TheraNews Logo

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

benzinga|3/17/2026|depression
Share this article:
Email

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

ONLY AVAILABLE IN PAID PLANS.


Originally reported by benzinga. Read more

Share this article:
Email

Related Articles

More stories about depression